Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 17 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.80 Insider Own3.31% Shs Outstand47.53M Perf Week-9.11%
Market Cap960.83M Forward P/E- EPS next Y-0.61 Insider Trans-0.60% Shs Float46.78M Perf Month-12.24%
Income-37.23M PEG- EPS next Q-0.17 Inst Own102.99% Short Float7.54% Perf Quarter-37.82%
Sales414.60M P/S2.32 EPS this Y-17.88% Inst Trans-1.47% Short Ratio4.83 Perf Half Y-45.44%
Book/sh9.43 P/B2.11 EPS next Y21.85% ROA-6.34% Short Interest3.53M Perf Year-59.57%
Cash/sh2.19 P/C9.07 EPS next 5Y20.00% ROE-8.17% 52W Range20.19 - 59.61 Perf YTD-44.35%
Dividend Est.- P/FCF- EPS past 5Y-1.17% ROI-7.04% 52W High-66.68% Beta1.43
Dividend TTM- Quick Ratio2.83 Sales past 5Y15.61% Gross Margin74.73% 52W Low-1.63% ATR (14)1.07
Dividend Ex-Date- Current Ratio4.00 EPS Y/Y TTM2.84% Oper. Margin-7.67% RSI (14)31.70 Volatility4.63% 4.61%
Employees1200 Debt/Eq0.17 Sales Y/Y TTM18.70% Profit Margin-8.98% Recom1.00 Target Price47.33
Option/ShortYes / Yes LT Debt/Eq0.16 EPS Q/Q-102.14% Payout- Rel Volume0.79 Prev Close20.76
Sales Surprise1.87% EPS Surprise-22.06% Sales Q/Q16.43% EarningsMay 01 AMC Avg Volume730.37K Price19.86
SMA20-10.75% SMA50-13.27% SMA200-39.80% Trades Volume576,789 Change-4.34%
Date Action Analyst Rating Change Price Target Change
Apr-23-24Upgrade Oppenheimer Perform → Outperform $32
Oct-23-23Initiated JMP Securities Mkt Outperform $60
Sep-29-23Initiated UBS Buy $56
Aug-05-21Downgrade Oppenheimer Outperform → Perform
Dec-18-20Reiterated Needham Buy $53 → $63
Nov-06-20Reiterated Needham Buy $63 → $53
Apr-07-20Initiated Oppenheimer Outperform $45
Feb-06-20Initiated BTIG Research Buy $42
Jan-24-20Reiterated Needham Buy $39 → $48
Aug-13-19Downgrade Northland Capital Outperform → Market Perform $30
May-31-24 07:00PM
May-15-24 08:00AM
May-02-24 03:18PM
08:57PM Loading…
May-01-24 08:57PM
Apr-30-24 08:00AM
Apr-23-24 07:07AM
Apr-19-24 09:45AM
Apr-18-24 08:00AM
08:00AM Loading…
Apr-10-24 08:00AM
Mar-26-24 08:00AM
Mar-22-24 06:40AM
Mar-07-24 09:01AM
Feb-28-24 12:47AM
Feb-16-24 11:30AM
Feb-15-24 07:00PM
Feb-12-24 09:16AM
Jan-25-24 08:00AM
Jan-08-24 08:00AM
08:00AM Loading…
Jan-04-24 08:00AM
Dec-20-23 08:00AM
Nov-15-23 09:55AM
Nov-14-23 08:00AM
Nov-06-23 12:00PM
Nov-02-23 03:14PM
Nov-01-23 06:22PM
Oct-31-23 08:00AM
Oct-11-23 08:00AM
Sep-29-23 09:40AM
Sep-11-23 11:45AM
Sep-09-23 07:32PM
Jul-29-23 01:10AM
Jul-27-23 08:50AM
Jul-26-23 07:49AM
Jul-25-23 08:00PM
Jul-21-23 08:00AM
Jul-03-23 08:00AM
May-25-23 04:02AM
May-04-23 06:21AM
May-03-23 10:50AM
May-02-23 05:25PM
Apr-19-23 08:00AM
Apr-17-23 10:42AM
Apr-11-23 08:00AM
Apr-03-23 08:00AM
Apr-01-23 09:41PM
Mar-27-23 08:29AM
Mar-18-23 09:14AM
Feb-25-23 02:14PM
Feb-21-23 05:15PM
Feb-17-23 08:00AM
Jan-31-23 08:00AM
Jan-24-23 08:00AM
Jan-09-23 08:00AM
Dec-31-22 08:07AM
Dec-20-22 08:00AM
Dec-08-22 10:30AM
Dec-04-22 07:20AM
Nov-08-22 08:00AM
Nov-01-22 05:55PM
Oct-26-22 10:01AM
Oct-25-22 10:01AM
Oct-11-22 08:00AM
Oct-09-22 08:53AM
Sep-06-22 08:00AM
Aug-16-22 08:00AM
Aug-02-22 05:15PM
Jul-28-22 09:44AM
Jul-20-22 08:00AM
Jul-12-22 08:00AM
Jul-06-22 07:09PM
Jun-18-22 09:31AM
Jun-07-22 08:00AM
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Privitera SalvatoreChief Technical OfficerMay 30 '24Buy22.255,000111,250103,290May 31 04:12 PM
Noznesky Justin JChief Mktg & Strategy OfficerMay 01 '24Sale24.091,50036,13571,284May 03 08:51 AM
Noznesky Justin JChief Mktg & Strategy OfficerApr 01 '24Sale30.391,50045,58572,784Apr 03 08:41 AM
Dahlquist Karl S.Chief Legal OfficerMar 18 '24Sale32.161,88560,62250,954Mar 20 08:41 AM
Noznesky Justin JChief Mktg & Strategy OfficerMar 12 '24Sale36.721,50055,08074,284Mar 14 08:55 AM
Dahlquist Karl S.Chief Legal OfficerMar 05 '24Sale37.368,231307,51052,839Mar 07 07:28 AM
Wirick Angela LChief Financial OfficerMar 01 '24Option Exercise16.955,00084,750139,070Mar 05 04:46 PM
WHITE ROBERT S.DirectorFeb 23 '24Option Exercise15.9610,000159,60088,985Feb 27 09:00 AM
Dahlquist Karl S.Chief Legal OfficerNov 01 '23Sale34.431,24842,96930,789Nov 03 08:40 AM
Dahlquist Karl S.Chief Legal OfficerJul 26 '23Sale57.093,417195,07732,037Jul 28 08:39 AM